TG
TRV GP Portfolio holdings
AUM
$18.9M
This Quarter Return
+48.45%
1 Year Return
+541.67%
3 Year Return
+3,178.87%
5 Year Return
–
10 Year Return
–
AUM
$159M
AUM Growth
+$159M
(+13%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-18.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
CytomX Therapeutics
CTMX
|
$29M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.85B
| $124M | 78.39% | 3,981,437 | – | – |
|
2
KALA BIO
KALA
$78.8M
| $22.7M | 14.31% | 1,654,425 | – | – |
|
3
Carisma Therapeutics
CARM
$8.98M
| $9.44M | 5.95% | 4,841,591 | – | – |
|
4
Larimar Therapeutics
LRMR
$310M
| $2.15M | 1.36% | 210,371 | – | – |
|
|
5
CytomX Therapeutics
CTMX
$336M
| – | – | -1,020,348 | Closed | -$29M |
|